Quantification of HTLV Type I and HIV Type 1 DNA Load in Coinfected Patients: HIV Type 1 Infection Does Not Alter HTLV Type I Proviral Amount in the Peripheral Blood Compartment
- 10 June 2001
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 17 (9) , 799-805
- https://doi.org/10.1089/088922201750251990
Abstract
Several reports suggest that HTLV-I/HIV coinfection may be associated with an increased risk of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). In HTLV-I-monoinfected patients, the occurrence of HAM/TSP is associated with high peripheral blood HTLV-I proviral load. Using a real-time quantitative PCR assay, we assessed the proviral DNA load in peripheral blood mononuclear cells (PBMCs) from 15 asymptomatic HTLV-I-monoinfected patients, 15 HTLV-I-monoinfected patients with HAM/TSP, and 25 HTLV-I/HIV-1 coinfected patients, including 4 with HAM/TSP. We also measured HIV-1 proviral DNA load in PBMCs from the coinfected patients. The median HTLV-I proviral loads were 6,800 and 4,100 copies per 106 PBMCs in the asymptomatic monoinfected and coinfected groups, and 58,800 and 43,300 copies per 106 PBMCs in the monoinfected and coinfected patients with HAM/TSP, respectively. The difference between HTLV-I proviral loads in HAM/TSP and asymptomatic monoinfected patients was statistically significant (p < 0.0001), but there was no difference between the HTLV-I-monoinfected and HTLV-I/HIV-1-coinfected groups. There was no correlation between HTLV-I and HIV-1 proviral load. HTLV-I proviral load did not correlate with the CD4+ T lymphocyte count. Among patients with no HTLV-I disease, the median copy number of HTLV-I per 106 circulating CD4+ T cells was 114,000 in the coinfected group and 16,700 in the monoinfected group, but the difference was not significant (p = 0.089). These data do not confirm the hypothesis in which HIV-1 coinfection would increase HTLV-I proviral burden in the PBMCs. However, depletion of the CD4+ T cell subset, the main target of HTLV-I, could be counterbalanced by an up-regulation of HTLV-I replication or by greater resistance of HTLV-I-infected cells to HIV-1-induced destruction.Keywords
This publication has 39 references indexed in Scilit:
- Coinfection of Macaques with Simian Immunodeficiency Virus and Simian T Cell Leukemia Virus Type I: Effects on Virus Burdens and Disease ProgressionThe Journal of Infectious Diseases, 1999
- Human T Cell Lymphotropic Virus Type I Does Not Increase Human Immunodeficiency Virus Viral Load In VivoThe Journal of Infectious Diseases, 1997
- Retroviral Coinfections at a New Orleans HIV Outpatient ClinicJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Laboratory study of HIV‐1 and HTLV‐I/II coinfectionJournal of Medical Virology, 1994
- Inhibition of Apoptosis in T Cells Expressing Human T Cell Leukemia Virus Type I TaxAIDS Research and Human Retroviruses, 1994
- Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progressionPublished by American Medical Association (AMA) ,1994
- American blood donors seropositive for human T-lymphotropic virus types I/II exhibit normal lymphocyte subsetsTransfusion, 1990
- Rapid Development of Myelopathy after HTLV-I Infection Acquired by Transfusion during Cardiac TransplantationNew England Journal of Medicine, 1990
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISPublished by Elsevier ,1985